Moneycontrol
Get App
Last Updated : May 22, 2020 04:01 PM IST | Source: Moneycontrol.com

Alembic Pharma Q4 profit jumps 81% to Rs 225 crore, FY20 net grows 42%

The company's revenue increased 30.2 percent to Rs 1,207 crore compared to the corresponding period last fiscal.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Alembic Pharmaceuticals on May 22 reported an 81 percent year-on-year jump in consolidated profit at Rs 224.63 crore for March quarter as revenue and operating performance remained strong.

Revenue from operations during the quarter increased 30.2 percent to Rs 1,207 crore compared to the corresponding period last fiscal.

On the operating front, earnings before interest, tax, depreciation and amortisation (EBITDA) shot up 84 percent year-on-year to Rs 327.52 crore in the January-March quarter.

Close

EBITDA margin expanded sharply to 27.13 percent in the quarter, up 793 basis points over 19.2 percent in the same period previous fiscal.

Full-year numbers, too, were impressive, with the profit rising 41.8 percent to Rs 828.82 crore and revenue up 17.1 percent at Rs 4,605.75 crore compared to the previous year.

Find All Earnings Related News Here

The stock, however, ended flat at Rs 898.05, up 0.12 percent, on the NSE.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

First Published on May 22, 2020 04:01 pm
Sections
Follow us on